alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IV 

114TH CONGRESS 

2D SESSION H. RES. 615 

Expressing support for the Senate regarding the importance of selecting 

a Supreme Court Justice, and urging the Senate to only consider a 

nominee who will uphold the integrity of the Constitution in judicial 

decisions. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 23, 2016 

Mr. FORBES submitted the following resolution; which was referred to the 

Committee on the Judiciary 

RESOLUTION 

Expressing support for the Senate regarding the importance 

of selecting a Supreme Court Justice, and urging the 

Senate to only consider a nominee who will uphold the 

integrity of the Constitution in judicial decisions. 

Whereas the sudden and tragic death of Justice Antonin 

Scalia on February 13, 2016, has left a vacancy on the 

Supreme Court of the United States; 

Whereas the Supreme Court is vested by article III of the 

United States Constitution with the judicial power of the 

United States, extending to all cases arising under the 

Constitution, the laws of the United States, and Treaties; 

Whereas the appointment of Justices to the Supreme Court 

under article II, section 2, clause 2 of the Constitution, 


emcdonald on DSK9F6TC42PROD with BILLS
2 

•HRES 615 IH 

is a constitutional duty dually shared by the President 

and by the United States Senate; 

Whereas though it is the President’s duty under the Constitution to nominate appointees to the Supreme Court, 

the President is not entitled to deference on the confirmation of those nominees; 

Whereas the Senate shares with the President an equal duty 

in reviewing and approving nominees to the Federal judiciary who will uphold the integrity and structure of the 

Constitution and the laws of the United States with consistency and integrity; and 

Whereas it is of the utmost importance that the vacancy that 

is left by Justice Scalia be filled with an individual who 

will uphold the Constitution, free from political bias or 

ideology: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) supports the Senate in its constitutional 

3 duty to vet and approve any nominee to the Su4 preme Court put forward by the President; and 

5 (2) urges that the Senate only consider a nomi6 nee who has demonstrated a faithful adherence to 

7 the limits placed on judicial power by the Constitu8 tion. 

Æ 


emcdonald on DSK9F6TC42PROD with BILLS
IV 

114TH CONGRESS 

2D SESSION H. RES. 698 

Amending the Rules of the House of Representatives to require the Committee 

on Appropriations to maintain proposed and historical budget authority 

and outlays for each category of spending. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 21, 2016 

Mr. BRAT (for himself, Mr. AMASH, Mr. JONES, Mr. BROOKS of Alabama, Mr. 

RIBBLE, and Mr. BABIN) submitted the following resolution; which was 

referred to the Committee on Rules 

RESOLUTION 

Amending the Rules of the House of Representatives to 

require the Committee on Appropriations to maintain 

proposed and historical budget authority and outlays for 

each category of spending. 

1 Resolved, That (a) clause 4(a) is amended by adding 

2 at the end the following new subparagraph: 

3 ‘‘(5)(A) The Committee on Appropriations shall 

4 maintain proposed and historical budget authority and 

5 outlays for each category of spending. Such data shall— 

6 ‘‘(i) cover a period comprising the 10 fiscal 

7 years immediately preceding the budget year; and 


asabaliauskas on DSK3SPTVN1PROD with BILLS
2 

•HRES 698 IH 

1 ‘‘(ii) be kept up-to-date and provided on the 

2 public Web site of the committee in a downloadable, 

3 searchable, and sortable format. 

4 ‘‘(B) As used in this subparagraph, the term ‘cat5 egory of spending’ includes— 

6 ‘‘(i) section 302(a) allocations and section 

7 302(b) suballocations and discretionary and direct 

8 spending authority for each department, agency, 

9 program, or other line item in any appropriation 

10 Act; and 

11 ‘‘(ii) discretionary and direct spending authority 

12 for each department, agency, and program as set 

13 forth in budget proposals of the Presidents sub14 mitted under section 1105(a) of title 31, United 

15 States Code.’’. 

16 (b) The amendment made by subsection (a) shall take 

17 effect immediately before noon on January 3, 2017. 

Æ 


asabaliauskas on DSK3SPTVN1PROD with BILLS
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Mobile Data Collection Tools:

Training Events

Last Modified: 

Print

Meant to step users through electronic field data collection, live training events are

approved and scheduled by pest program managers.  Supervisors should review and

recommend attendance as appropriate to data collection needs.  

Zoom registration may be completed ahead using the links below and are inclusive

of Federal employees and State cooperators.  

There are no training events scheduled at this time. Check back soon for information

about upcoming 2024 trainings!

Training On Demand

Completed trainings are available on the Mobile Data Collection Tools web page.  

View the Mobile Data Collection Tools Training Catalog
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-2000             SEP-30-1999
<PERIOD-START>                             OCT-01-1999             OCT-01-1998
<PERIOD-END>                               DEC-31-1999             DEC-31-1998
<CASH>                                          62,737                  81,912
<SECURITIES>                                   176,520                 145,308
<RECEIVABLES>                                   79,326                  70,034
<ALLOWANCES>                                     3,705                   1,000
<INVENTORY>                                     29,402                  26,931
<CURRENT-ASSETS>                               339,502                 317,502
<PP&E>                                         140,882                 129,506
<DEPRECIATION>                                  54,899                  50,783
<TOTAL-ASSETS>                                 560,291                 522,893
<CURRENT-LIABILITIES>                           29,719                  35,480
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                         1,574                   1,561
<OTHER-SE>                                     400,270                 380,035
<TOTAL-LIABILITY-AND-EQUITY>                   560,291                 522,893
<SALES>                                         89,223                  60,708
<TOTAL-REVENUES>                                89,223                  60,708
<CGS>                                           31,624                  23,225
<TOTAL-COSTS>                                   56,739                  42,025
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                                 35,278                  21,164
<INCOME-TAX>                                    11,642                   6,560
<INCOME-CONTINUING>                             23,636                  14,604
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    23,636                  14,604
<EPS-BASIC>                                        .15                     .10
<EPS-DILUTED>                                      .14                     .09


</TABLE>
**EXHIBIT31.2**

CERTIFICATIONPURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a)

OFTHE SECURITIES EXCHANGE ACT OF 1934,

ASADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James G. Thomasch, certify that:

1. I have reviewed this quarterly report on Form 10-Q of PLC SystemsInc.;

2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to makethe statements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designedunder our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisreport is being prepared;

b) [Not Applicable];

c) Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as of theend of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarterin the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financialreporting; and

5. The registrant’s other certifying officer and I have disclosed,based on our most recent evaluation of internal control over financialreporting, to the registrant’s auditors and the audit committee of theregistrant’s board of directors (or persons performing the equivalentfunctions):

a) All significant deficiencies and materialweaknesses in the design or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant’s ability torecord, process, summarize and report financial information; and

b) Any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theregistrant’s internal controls over financial reporting.
| Date: May 15, 2007 |   | /s/ James G. Thomasch   |
|--------------------|--------|-------------------------|
|               |   | James G. Thomasch       |
|               |   | Chief Financial Officer |

 

----
EX-10.1D



 Exhibit 10.1D 

FOURTH AMENDMENT 
 To The

 RE-ESTABLISHED RETIREMENT PLAN FOR SALARIED EMPLOYEES OF 

KEWAUNEE SCIENTIFIC CORPORATION  

(As Amended and Restated Effective as of May 1, 2012) 

THIS AMENDMENT, made and executed by Kewaunee Scientific Corporation (the “Company”): 

W I T N E S S E T H 
 WHEREAS,
the Company maintains the Re-Established Retirement Plan for Salaried Employees of Kewaunee Scientific Corporation, as amended from time to time (the “Plan”); and 

WHEREAS, pursuant to Section 12.2 of the Plan, the Company has reserved the right to amend the Plan from time to time; and 

WHEREAS, the Board of Directors of the Company has determined to amend the Plan, effective as of July 1, 2018 and notwithstanding any
other provision of the Plan, to allow eligible participants whose accrued benefits have a present value that does not exceed $10,000 to elect distribution of their benefits under the Plan in the form of a lump sum rather than a monthly annuity; 

NOW THEREFORE, the Plan is amended as set forth below, effective as of July 1, 2018: 

 

	 	1.	Section 7.5(b) of the Plan is amended in its entirety to read as follows: 

 “(b)
Effective for commencement of Pensions on or after July 1, 2018, if the present value of a Pension payable under the Plan, as determined under paragraph (a), is more than $5,000 but not more than $10,000 as of the determination date, the
Participant or Beneficiary may elect to receive payment of such Pension in a lump sum. In the case of a Pension payable to a Participant, such election shall be considered a selection of an optional form of benefit, and the notice, election and
spousal consent provisions of Section 7.4 shall apply. Subject to such provisions of Section 7.4, payment of a lump sum elected pursuant to this Section 7.5(b) may be made as soon as practicable following the date on which a
Participant has incurred a termination of employment or, in the case of a payment to a Beneficiary, the Participant’s death.” 







 IN WITNESS WHEREOF, the Company has caused this Fourth Amendment to the Re-Established Retirement Plan for Salaried Employees of Kewaunee Scientific Corporation to be properly executed on the 28 day of June, 2018. 

 

			
	KEWAUNEE SCIENTIFIC CORPORATION
	
	Pursuant to approval of the Board of Directors
		
	By:	 	 /s/ Thomas D. Hull III

	Name:	 	Thomas D. Hull III
	Title:	 	CFO



  
 2
According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a person is not required to respond to, a collection of 

information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0579-0256. The time 

required to complete this information collection is estimated to average 20 minutes per response, including the time for reviewing instructions, searching 

existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.

OMB Approved

0579-0256

UNITED STATES DEPARTMENT OF AGRICULTURE

ANIMAL AND PLANT HEALTH INSPECTION SERVICE

EXPORT CERTIFICATE FOR

ANIMAL PRODUCTS

Port:

FOR OFFICIAL USE ONLY

Date:

Certificate Number:

This certificate is for veterinary purposes only. It is valid for 30 days after the date of signature (in the case of transport by ship or rail, the time is prolonged by the time of the 

voyage).

ADDITIONAL DECLARATIONS

SIGNATURE OF ENDORSING OFFICIAL: NAME OF ENDORSING OFFICIAL: 

TITLE OF ENDORSING OFFICIAL:

DESCRIPTION OF THE CONSIGNMENT

NAME AND ADDRESS OF EXPORTER: NAME AND ADDRESS OF CONSIGNEE:

PRODUCT (type of product, quantity, unit of measure, and animal product species of origin):

IDENTIFICATION: CONVEYANCE:

VS Form 16-4 

JUL 2022
<PAGE>
 
                                                                      EXHIBIT 11


                                 COMPUSA INC.
                               CONMPUTATIONS OF
                 INCOME PER COMMON AND COMMON EQUIVALENT SHARE
                     (in thousands, except per share data)
<TABLE>
<CAPTION>
 
                                                 Thirteen Weeks Ended
                                              ----------------------------  
                                              September 28,  September 23,
                                                  1996           1995
                                              -------------  ------------- 
<S>                                           <C>            <C>
Common shares outstanding at beginning           
 of period.................................          44,918         40,466
Weighted average number of common
 shares issued during the period...........             129            314
 
Incremental shares related to assumed
 exercise of stock options.................           2,223          1,755
                                               ------------  -------------
Weighted common and common equivalent                
 shares....................................          47,270         42,535   
                                               ============  =============
Net income.................................     $    14,546  $       6,207
                                               ============  =============
Income per common and common equivalent         
 share (1).................................     $      0.31          $0.15
                                               ============  =============
</TABLE>

(1) The computation of income per common share on a fully diluted basis does not
    materially differ from the amounts calculated on a primary basis shown
    above.

                                      16
An equal opportunity employer 

Thomas M. Gray 

211(b) Technical Manager 

1220 L Street, Northwest

Washington, DC 20005-4070

Tel 202-682-8480 

Fax 202-682-8270 

E-mail grayt@api.org

June 9, 2010 

Karl Simon 

Division Director 

Compliance and Innovative Strategies Division 

Office of Transportation and Air Quality 

1200 Pennsylvania Avenue, N. W. 

Mail Code: 6406J 

Washington, DC 20460 

RE: CAA Section 211(b) Fuels and Fuel Additives Health Effects Testing Regulation: Final Submission 

for 211(b) (Docket No. A-90-07) 

211(b) Chronic Carcinogenicity Study Baseline Gasoline Vapor Condensate (BGVC) (LRRI Study 

No. FY01-027) 

Dear Mr. Karl Simon: 

The American Petroleum Institute (API), on behalf of the Section 211(b) Research Group (RG), is submitting the 

following information to EPA as partial fulfillment of the CAA Section 211(b) Alternative Tier 2 requirements of 

the testing regulation: 

• 211(b) Chronic Carcinogenicity Study Baseline Gasoline Vapor Condensate (BGVC) (LRRI 

Study No. FY01-027)

The Final Report has undergone review by two independent peer-reviewers, outside QA/QC, EPA and the 211(b) 

Technical Workgroup. Therefore the report is being submitted to you at the EPA Office of Transportation and 

Air Quality, Transportation and Regional Programs Division, as part of the requirements of Clean Air Act Section 

211(b)(2) and 211(e) (Docket No. A-90-07). If you require further information or have any questions regarding 

this submission, please contact me. 

Regards, 

 

Thomas M. Gray, M.S., DABT 

Encl (1): 211(b) Chronic Carcinogenicity Study Baseline Gasoline Vapor Condensate (BGVC) (LRRI Study 

No. FY01-027) 

Cc: Joe Sopata, EPA
Annex 13

**USA COMMENTS IN RED FONT**

CHAPTER 8.16.**INFECTION WITH RIFT VALLEY FEVER VIRUS**

[...]

Article 8.16.8.

Recommendations for importation of semen and *in vivo*derived embryos of susceptible animals from countries or zones infected with Rift Valley fever virus (RVFV)

**RATIONALE:**Spelling out for first use.

*Veterinary Authorities* should require the presentation of an *international veterinary certificate* attesting that the donor animals:

1)	showed no clinical signs of RVF within the period from 14 days prior to and 14 days following collection of the semen or embryos;

AND

2)	either:

a)	were vaccinated against RVF at least 14 days prior to collection; or

b)	were subjected to a serological test on the day of collection, with positive result; or

c)	were subjected to a serological test on two occasions with negative results on the day of collection and at least 14 days after collection~~.~~; or

d)were subjected to a test for the detection of the agent with negative result on the day of collection. 

[...]

___________________________

Report of the Meeting of the WOAH Terrestrial Animal Health Standards Commission/September 2023	1
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Indevus Pharmaceuticals, Inc. (the Company) on
Form 10-K for the period ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Glenn L. Cooper, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|    |  |                        
|--- |  | -----------------------
|    | 
|By: |  | /s/    Glenn L.
Cooper 
|    |  | Chief Executive Officer

December 10, 2008
Michigan Supreme Court

Lansing, Michigan

Marilyn Kelly,

 Chief Justice

Michael F. Cavanagh

Maura D. Corrigan

Robert P. Young, Jr.

Stephen J. Markman

Diane M. Hathaway

Alton Thomas Davis, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

September 9, 2010 

p0830 

Order 

 

September 9, 2010 

141201 

PEOPLE OF THE STATE OF MICHIGAN, 

Plaintiff-Appellee, 

v SC: 141201 

 COA: 297005 

Saginaw CC: 08-031393-FJ 

ALEX NOWAND ALEXANDER, 

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the May 4, 2010 order of 

the Court of Appeals is considered, and it is DENIED, because we are not persuaded that 

the question presented should be reviewed by this Court.
United States Court of Appeals

For the First Circuit

No. 14-1369

No. 14-1371

UNITED STATES OF AMERICA,

Appellee,

v.

JUAN G. QUIÑONES-MELÉNDEZ,

Defendant, Appellant.

ERRATA SHEET

The opinion of this Court issued on July 1, 2015 is amended

as follows:

On page 12, line 10, an "a" is inserted between "of" and

"substantively."
EXHIBIT
      32.1




CERTIFICATION
      OF PRINCIPAL EXECUTIVE


PURSUANT
      TO 18 U.S.C. SECTION 1350,


AS
      ADOPTED PURSUANT TO SECTION 906


OF
      THE
      SARBANES-OXLEY ACT OF 2002




In
      connection with the filing by Ionatron, Inc. (the “Company”) of its Quarterly
      Report on Form 10-Q for the quarterly period ended March 31, 2007 (the “Report”)
      I, Dana A. Marshall, Chief Executive Officer of the Company certify pursuant
      to
      18 U.S.C. Section. 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002 that:


(i)
              the
                  Report fully complies with the requirements of Section 13(a) or
                  15(d) of
                  the Securities Exchange Act of 1934;
                  and




(ii)
            the
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operation of the
                Company.




This
      certificate is being made for the exclusive purpose of compliance by the Chief
      Executive Officer of Ionatron, Inc. with the requirements of Section 906 of
      the
      Sarbanes-Oxley Act of 2002, and may not be used for any other purposes. A signed
      original of this written statement required by Section 906 has been provided
      to
      Ionatron, Inc. and will be retained by Ionatron, Inc. and furnished to the
      Securities and Exchange Commission or its staff upon request.




/s/ Dana
              A.
              MarshallDana
                A. Marshall
              Chief
                Executive Officer




Date:
      May
      10, 2007